Arie Perry Selected Research

Arie Perry Research Topics

Disease

117	Neoplasms (Cancer) 05/2024 - 01/2002
35	Meningioma (Meningiomas) 05/2024 - 05/2002
34	Glioma (Gliomas) 09/2023 - 09/2007
20	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 07/2004
19	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 12/2002
14	Neurofibrosarcoma (MPNST) 01/2020 - 02/2004
9	Brain Neoplasms (Brain Tumor) 11/2020 - 11/2004
8	Oligodendroglioma 12/2017 - 05/2003
7	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 01/2006
7	Neoplasm Metastasis (Metastasis) 03/2020 - 02/2004
7	Medulloblastoma 01/2019 - 07/2004
7	Ependymoma 07/2013 - 05/2002
6	Neurilemmoma (Schwannoma) 01/2024 - 12/2005
5	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 05/2008
4	Carcinogenesis 05/2024 - 09/2010
4	Ganglioglioma 01/2022 - 09/2011
4	Necrosis 02/2015 - 03/2006
3	Disease Progression 01/2020 - 01/2006
3	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2020 - 01/2010
3	Neurofibroma 01/2017 - 12/2005
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2017 - 09/2007
2	Neuroblastoma 03/2024 - 03/2007
2	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 12/2023 - 12/2005
2	Hemangioma (Angioma) 01/2021 - 08/2008
2	Neurocytoma 01/2020 - 07/2004
2	Epilepsy (Aura) 10/2019 - 01/2018
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019 - 01/2011
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2018 - 12/2017
2	Chordoma 05/2017 - 11/2014
2	Meningitis 05/2017 - 10/2016
2	Gliosarcoma 10/2016 - 05/2013
2	Monosomy 01/2016 - 05/2008
2	Typical Teratoid Rhabdoid Tumor 12/2012 - 05/2005
2	Adenocarcinoma 12/2010 - 07/2006

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2002
21	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2005
12	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 05/2002
10	RNA (Ribonucleic Acid)IBA 05/2024 - 04/2011
9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 09/2011
9	Histones (Histone)IBA 03/2020 - 04/2013
8	Phosphotransferases (Kinase)IBA 01/2022 - 07/2009
8	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2005
7	Neurofibromin 2 (Merlin)IBA 01/2023 - 05/2002
6	Neurofibromin 1 (Neurofibromin)IBA 01/2020 - 09/2003
5	SynaptophysinIBA 03/2024 - 03/2007
5	Transcription Factors (Transcription Factor)IBA 12/2023 - 06/2007
5	Temozolomide (Temodar)FDA LinkGeneric 12/2017 - 03/2008
4	Hormones (Hormone)IBA 01/2023 - 11/2012
4	MucinsIBA 01/2021 - 11/2004
4	AntigensIBA 12/2016 - 01/2005
4	ParaffinIBA 05/2015 - 12/2002
4	AntibodiesIBA 03/2013 - 10/2004
4	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2012 - 11/2004
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 08/2017
3	Keratins (Keratin)IBA 01/2023 - 01/2020
3	CateninsIBA 01/2023 - 03/2011
3	Lysine (L-Lysine)FDA Link 01/2020 - 04/2013
3	2,6-dinitrotoluene (DNT)IBA 01/2020 - 01/2010
3	SteroidsIBA 10/2016 - 02/2007
3	LigandsIBA 04/2016 - 02/2004
3	Small Interfering RNA (siRNA)IBA 09/2015 - 03/2006
3	Formaldehyde (Formol)FDA Link 05/2015 - 01/2006
3	Genetic Markers (Genetic Marker)IBA 10/2014 - 11/2004
3	Cyclic AMP (AMP, Cyclic)IBA 12/2008 - 01/2007
3	OligonucleotidesIBA 03/2006 - 08/2002
2	AZD 6244IBA 01/2024 - 08/2017
2	ChromatinIBA 01/2024 - 12/2023
2	Protein Isoforms (Isoforms)IBA 12/2023 - 12/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2023 - 09/2007
2	ProlactinIBA 09/2023 - 12/2017
2	Growth Hormone (Somatotropin)IBA 09/2023 - 12/2017
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2023 - 12/2017
2	Brachyury protein (Brachyury)IBA 01/2023 - 11/2014
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 08/2017
2	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 07/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 02/2004
2	DesminIBA 01/2021 - 01/2020
2	Mutant Proteins (Protein, Mutant)IBA 12/2017 - 05/2013
2	Amylases FDA Link 08/2017 - 07/2005
2	Rituximab (Mabthera)FDA Link 10/2016 - 09/2011
2	Mucin-1 (CA 15-3 Antigen)IBA 09/2015 - 11/2004
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2015 - 12/2005
2	NestinIBA 08/2015 - 01/2005
2	Tumor Biomarkers (Tumor Markers)IBA 06/2015 - 08/2005
2	PlatinumIBA 09/2014 - 01/2009
2	MicroRNAs (MicroRNA)IBA 08/2014 - 12/2012
2	Bevacizumab (Avastin)FDA Link 07/2014 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 08/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2013 - 01/2013
2	Complementary DNA (cDNA)IBA 11/2012 - 07/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2012 - 03/2006
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2012 - 08/2003
2	Cadherins (E-Cadherin)IBA 09/2010 - 07/2005
2	beta CateninIBA 09/2010 - 07/2004

Therapy/Procedure

38	Therapeutics 05/2024 - 07/2004
16	Radiotherapy 05/2024 - 04/2004
11	Drug Therapy (Chemotherapy) 03/2024 - 04/2004
4	Immunotherapy 09/2023 - 11/2016
2	Neoadjuvant Therapy 01/2021 - 01/2017
2	Ventriculoperitoneal Shunt 03/2020 - 05/2017